HomeGLSI • NASDAQ
add
Greenwich Lifesciences Inc
Previous close
$12.89
Day range
$12.02 - $13.18
Year range
$7.58 - $21.44
Market cap
155.08M USD
Avg Volume
52.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.50M | 5.03% |
Net income | -2.39M | -3.14% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.50M | -5.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.14M | -41.53% |
Total assets | 9.15M | -41.53% |
Total liabilities | 297.29K | 24.97% |
Total equity | 8.85M | — |
Shares outstanding | 12.85M | — |
Price to book | 18.68 | — |
Return on assets | -62.26% | — |
Return on capital | -64.17% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -2.39M | -3.14% |
Cash from operations | -1.80M | -16.18% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.80M | -16.18% |
Free cash flow | -1.57M | -5.94% |
About
Founded
2006
Headquarters
Website
Employees
3